EMEA-001672-PIP01-14
Key facts
| Invented name |
|
| Active substance |
varicella-zoster virus (live, attenuated)
|
| Therapeutic area |
Vaccines
|
| Decision number |
P/0309/2014
|
| PIP number |
EMEA-001672-PIP01-14
|
| Pharmaceutical form(s) |
Powder and solvent for suspension for injection
|
| Route(s) of administration |
|
| Contact for public enquiries |
Sanofi Pasteur MSD SNC
|
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|